Documentation Centre

December 12, 2017
Secondary prevention of cardiovascular disease in patients with type 2 diabetes mellitus: International insights from the TECOS trial (Trial Evaluating Cardiovascular Outcomes With Sitagliptin). Circulation. 2017;136:1193-1203
Pagidipati NJ, Navar AM, Pieper KS, Green JB, Bethel MA, Armstrong PW, Josse RG, McGuire DK, Lokhnygina Y, Cornel JH, Halvorsen S, Strandberg TE, Delibasi T, Holman RR, Peterson ED; TECOS Study Group

Description of this Publication

Consult publication on external website

By clicking on this link, you will leave the INTERNATIONAL CHAIR ON CARDIOMETABOLIC RISK website

Key Words
Cardiovascular Disease, Diabetes, Prevention